Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023

SELL
$0.35 - $0.72 $165 - $341
-474 Reduced 28.55%
1,186 $0
Q2 2023

Aug 14, 2023

BUY
$0.33 - $0.48 $346 - $504
1,050 Added 172.13%
1,660 $0
Q1 2023

May 15, 2023

BUY
$0.44 - $5.47 $264 - $3,292
602 Added 7525.0%
610 $0
Q4 2022

Feb 14, 2023

SELL
$1.88 - $3.85 $1,139 - $2,333
-606 Reduced 98.7%
8 $0
Q3 2022

Nov 14, 2022

SELL
$1.46 - $2.55 $1,076 - $1,879
-737 Reduced 54.55%
614 $1,000
Q2 2022

Aug 15, 2022

SELL
$1.03 - $2.03 $1,427 - $2,813
-1,386 Reduced 50.64%
1,351 $3,000
Q1 2022

May 16, 2022

SELL
$1.7 - $5.72 $7,777 - $26,169
-4,575 Reduced 62.57%
2,737 $6,000
Q4 2021

Feb 14, 2022

BUY
$4.95 - $7.11 $18,072 - $25,958
3,651 Added 99.73%
7,312 $38,000
Q3 2021

Nov 15, 2021

BUY
$6.96 - $9.25 $5,011 - $6,660
720 Added 24.48%
3,661 $26,000
Q2 2021

Aug 16, 2021

BUY
$8.05 - $11.61 $23,675 - $34,145
2,941 New
2,941 $29,000

About Frequency Therapeutics, Inc.


  • Ticker FREQ
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 35,262,000
  • Description
  • Frequency Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing therapeutics to activate a person's innate regenerative potential to restore function. Its Progenitor Cell Activation approach uses small molecules and activate progenitor cells within the body to create functional tissue. The company's lead product candi...
More about FREQ
Track This Portfolio

Track Royal Bank Of Canada Portfolio

Follow Royal Bank Of Canada and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

News

Stay updated on Royal Bank Of Canada with notifications on news.